CCR4 and neoplasm: In HL-bearing humanized mice, chimeric defucosylated anti-CCR4 mAb (KM2760) dramatically boosted the number of tumor-infiltrating NK cells that mediate ADCC and decreased the number of tumor-infiltrating FOXP3-positive Treg cells (50).